360° Intelligence From Samples to Biomarkers: QuartzBio® Platform
Data produced during preclinical and clinical development tend to be messy, disorganized, and decentralized, which makes interpretation and utilization of these data highly challenging.
Built on the first AI-enabled Biomarker Intelligence platform, powered by the first Precision Medicine Large Language Model (LLM) Ecosystem, QuartzBio® Software-as-a-Service (SaaS) products transform the way drug development teams interact with and extract insights from biospecimen and biomarker data.
Harness insights from your sample and biomarker data
Scalable QuartzBio® Software-as-a-Service (SaaS) products put the power of virtual Sample Inventory Management (vSIM) and enterprise Biomarker Data Management (eBDM) at your fingertips by creating a connected data ecosystem across the precision medicine lifecycle, using the first ensemble of Precision Medicine large language models (LLMs).
Unlocking the value of complex sample and biomarker data: Clinical Omics
Gaining insights from high-quality data is as easy as asking a question
QuartzBio’s AI-enabled Biomarker Intelligence platform shortens the time from data to insights. To build a high-quality data asset, QuartzBio’s Data Management tools automatically ingest data, map to a standardized data model, and check data to surface anomalies.
On top of your data asset and our sample and biomarker intelligence tools for data exploration and reporting, our conversational AI Virtual Assistant streamlines all user tasks to speed up decision-making.